To me the results seem too all over the place. I admit the drug may work, but I think it is unlikely.
Some doses work and others don't. Some doses work in one trial but not another. Too me the evidence is not consistent enough, and I expect the next Phase 2B will show more of the same - unexpected and inconclusive results.
As a quick experiment I just flipped three different coins 5 times - coins 1 and 2 came up heads 4 out of the 5 times and coin 3 came up heads 1 out of 5 times. I could claim that coins 1 and 2 are therefore more likely than coin 3 to produce a head, but I would be wrong.
Ed
- Forums
- ASX - By Stock
- MBP
- dose
dose, page-11
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries